IS8125A - Kínasólínafleiður til að meðhöndla krabbamein - Google Patents

Kínasólínafleiður til að meðhöndla krabbamein

Info

Publication number
IS8125A
IS8125A IS8125A IS8125A IS8125A IS 8125 A IS8125 A IS 8125A IS 8125 A IS8125 A IS 8125A IS 8125 A IS8125 A IS 8125A IS 8125 A IS8125 A IS 8125A
Authority
IS
Iceland
Prior art keywords
cancer
treatment
quinazoline derivatives
quinazoline
derivatives
Prior art date
Application number
IS8125A
Other languages
English (en)
Inventor
Murdoch Heron Nicola
Rene Pasquet Georges
Austen Mortlock Andrew
Henri Jung Frederic
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IS8125A publication Critical patent/IS8125A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IS8125A 2003-04-16 2005-11-11 Kínasólínafleiður til að meðhöndla krabbamein IS8125A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03290951 2003-04-16
PCT/GB2004/001614 WO2004094410A1 (en) 2003-04-16 2004-04-14 Chemical compounds

Publications (1)

Publication Number Publication Date
IS8125A true IS8125A (is) 2005-11-11

Family

ID=33305809

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8125A IS8125A (is) 2003-04-16 2005-11-11 Kínasólínafleiður til að meðhöndla krabbamein

Country Status (22)

Country Link
US (1) US7691867B2 (is)
EP (1) EP1613619B1 (is)
JP (1) JP4709139B2 (is)
KR (1) KR20060003351A (is)
CN (1) CN1809557B (is)
AR (1) AR043875A1 (is)
AT (1) ATE390422T1 (is)
AU (1) AU2004232527A1 (is)
BR (1) BRPI0409427A (is)
CA (1) CA2522079A1 (is)
CL (1) CL2004000797A1 (is)
CO (1) CO5640037A2 (is)
DE (1) DE602004012725T2 (is)
ES (1) ES2301981T3 (is)
IS (1) IS8125A (is)
MX (1) MXPA05011076A (is)
NO (1) NO20054842L (is)
RU (1) RU2005135337A (is)
TW (1) TW200510392A (is)
UY (1) UY28271A1 (is)
WO (1) WO2004094410A1 (is)
ZA (1) ZA200508372B (is)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003055491A1 (en) * 2001-12-24 2003-07-10 Astrazeneca Ab Substituted quinazoline derivatives as inhibitors of aurora kinases
SI1847539T1 (sl) * 2002-12-24 2010-01-29 Astrazeneca Ab Kinazolinski derivati
ATE401080T1 (de) * 2003-06-02 2008-08-15 Astrazeneca Ab (3-((chinazolin-4-yl)amino)-1h-pyrazol-1- yl)acetamid derivate und verwandte verbindungen als aurora kinase inhibitoren zur behandlung von proliferativen erkrankungen wie krebs
EP1694686A1 (en) 2003-12-19 2006-08-30 Takeda San Diego, Inc. Kinase inhibitors
KR20080095915A (ko) 2004-05-06 2008-10-29 워너-램버트 캄파니 엘엘씨 4-페닐아미노-퀴나졸린-6-일-아미드
WO2006023931A2 (en) 2004-08-18 2006-03-02 Takeda San Diego, Inc. Kinase inhibitors
JP2008515960A (ja) * 2004-10-12 2008-05-15 アストラゼネカ アクチボラグ キノリン誘導体
US20090036474A1 (en) * 2004-10-12 2009-02-05 Patrick Ple Quinazoline derivatives for use against cancer
BRPI0516093A (pt) 2004-10-12 2008-08-19 Astrazeneca Ab derivado de quinazolina, processo para a preparação do mesmo, composição farmacêutica, uso de um derivado de quinazolina, e, método para tratamento de distúrbios proliferativos celulares em um animal de sanque quente
EP1812439B2 (en) 2004-10-15 2017-12-06 Takeda Pharmaceutical Company Limited Kinase inhibitors
MX2007005863A (es) 2004-11-17 2007-10-19 Rexahn Pharmaceuticals Inc Derivados de 1-[(6,7-alcoxiquinoxalinil 6,7-sustituido) aminocarbonil]-4-(hetero)arilpiperazina.
GB0510963D0 (en) * 2005-05-28 2005-07-06 Astrazeneca Ab Chemical compounds
WO2006129064A1 (en) * 2005-05-28 2006-12-07 Astrazeneca Ab Quinazolines and their use as aurora kinase inhibitors
US20080269500A1 (en) * 2005-09-22 2008-10-30 Astrazeneca Ab Process for the Preparation of 4-Aminopyrazole Derivatives
US8119655B2 (en) 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
GB0601215D0 (en) * 2006-01-21 2006-03-01 Astrazeneca Ab Chemical compounds
UY30183A1 (es) 2006-03-02 2007-10-31 Astrazeneca Ab Derivados de quinolina
EP1994023A1 (en) * 2006-03-02 2008-11-26 AstraZeneca AB Quinazoline derivatives
WO2007113565A1 (en) * 2006-04-06 2007-10-11 Astrazeneca Ab Naphthyridine derivatives as anti-cancer agents
GB0609617D0 (en) 2006-05-16 2006-06-21 Astrazeneca Ab Process & intermediate
SG158147A1 (en) 2006-10-09 2010-01-29 Takeda Pharmaceutical Kinase inhibitors
FR2908409B1 (fr) 2006-11-10 2009-01-09 Sanofi Aventis Sa Pyrazoles substituees,compositions les contenant,procede de fabrication et utilisation
AR092289A1 (es) * 2011-11-14 2015-04-15 Sunshine Lake Pharma Co Ltd Derivados de aminoquinazolina y sus sales y metodos de uso
CN103012428A (zh) * 2013-01-08 2013-04-03 中国药科大学 4-(五元杂环并嘧啶/吡啶取代)氨基-1H-3-吡唑甲酰胺类CDK/Aurora双重抑制剂及其用途
CN104098551B (zh) * 2013-04-03 2019-03-22 广东东阳光药业有限公司 作为欧若拉激酶抑制剂的取代喹唑啉类衍生物
CN103382158B (zh) * 2013-07-29 2015-11-18 张家港市大伟助剂有限公司 一种2-环戊基氨基乙醇的制备方法
EP3046917B1 (en) * 2013-09-19 2017-11-08 Pierre Fabre Médicament Quinazoline derivatives and their use as dna methyltransferase inhibitors
WO2025162459A1 (zh) * 2024-02-02 2025-08-07 北京大学 新配体靶向化合物、螯合物、组合物及其用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5710158A (en) * 1991-05-10 1998-01-20 Rhone-Poulenc Rorer Pharmaceuticals Inc. Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
TW321649B (is) * 1994-11-12 1997-12-01 Zeneca Ltd
EP0860433B1 (en) * 1995-11-07 2002-07-03 Kirin Beer Kabushiki Kaisha Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of growth factor receptor originating in platelet and pharmaceutical compositions containing the same
CA2384291A1 (en) * 1999-09-21 2001-03-29 Astrazeneca Ab Quinazoline derivatives and their use as pharmaceuticals
GB9922171D0 (en) * 1999-09-21 1999-11-17 Zeneca Ltd Chemical compounds
IL153246A0 (en) * 2000-06-28 2003-07-06 Astrazeneca Ab Substituted quinazoline derivatives and their use as inhibitors
WO2003055491A1 (en) 2001-12-24 2003-07-10 Astrazeneca Ab Substituted quinazoline derivatives as inhibitors of aurora kinases
WO2004018430A1 (ja) * 2002-08-23 2004-03-04 Kirin Beer Kabushiki Kaisha ＴＧＦβ阻害活性を有する化合物およびそれを含んでなる医薬組成物
MXPA05006920A (es) * 2002-12-24 2006-02-10 Astrazeneca Ab Compuestos de quinazolina.
SI1847539T1 (sl) * 2002-12-24 2010-01-29 Astrazeneca Ab Kinazolinski derivati
WO2004058782A1 (en) 2002-12-24 2004-07-15 Astrazeneca Ab Therapeutic quinazoline derivatives
ATE401080T1 (de) * 2003-06-02 2008-08-15 Astrazeneca Ab (3-((chinazolin-4-yl)amino)-1h-pyrazol-1- yl)acetamid derivate und verwandte verbindungen als aurora kinase inhibitoren zur behandlung von proliferativen erkrankungen wie krebs
TW200505452A (en) * 2003-06-17 2005-02-16 Astrazeneca Ab Chemical compounds

Also Published As

Publication number Publication date
RU2005135337A (ru) 2006-06-10
ZA200508372B (en) 2007-04-25
DE602004012725T2 (de) 2009-04-16
ES2301981T3 (es) 2008-07-01
UY28271A1 (es) 2004-11-30
ATE390422T1 (de) 2008-04-15
CL2004000797A1 (es) 2005-05-27
MXPA05011076A (es) 2006-01-24
EP1613619B1 (en) 2008-03-26
DE602004012725D1 (de) 2008-05-08
NO20054842L (no) 2005-11-08
US20060270692A1 (en) 2006-11-30
AU2004232527A1 (en) 2004-11-04
CN1809557B (zh) 2012-07-04
WO2004094410A1 (en) 2004-11-04
BRPI0409427A (pt) 2006-04-18
CA2522079A1 (en) 2004-11-04
HK1086573A1 (en) 2006-09-22
AR043875A1 (es) 2005-08-17
CN1809557A (zh) 2006-07-26
JP4709139B2 (ja) 2011-06-22
JP2006523660A (ja) 2006-10-19
TW200510392A (en) 2005-03-16
US7691867B2 (en) 2010-04-06
EP1613619A1 (en) 2006-01-11
KR20060003351A (ko) 2006-01-10
CO5640037A2 (es) 2006-05-31

Similar Documents

Publication Publication Date Title
IS8125A (is) Kínasólínafleiður til að meðhöndla krabbamein
LTPA2019511I1 (lt) Rapamicino darinys, skirtas plaučių vėžio gydymui
IS8398A (is) Lyfjasamsetningar til að meðhöndla æxli
DK1292594T3 (da) Quinazolinderivater til behandling af tumorer
DK1765391T3 (da) Bakterielle præparater til behandlingen af cancer
DE602004004553D1 (de) Chinazolinderivate
DE602004022180D1 (de) Chinazolinderivate
DK1847539T3 (da) Quinazolin-derivater
DK1499730T3 (da) Immunokonjugater til behandling af tumorer
CY2015003I1 (el) Φαρμακευτικες συνθεσεις για θεραπεια καρκινου
DK1803718T3 (da) 4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter
IS7691A (is) Lyfjasamsetningar til að meðhöndla æxli
IL227841A0 (en) Dihydropyridinones for the treatment of cancer
IS7362A (is) Kínasólín efnasambönd
ATE450528T1 (de) Chinazolinderivate als antitumormittel
NL1029763A1 (nl) Bereiding van gesubstitueerde chinazolinen.
IS6917A (is) Epóþílon afleiður til meðhöndlunar erfiðra æxla
IS7137A (is) Samsett meðferð til meðhöndlunar á krabbameini
DK1694122T3 (da) N-arylhydrazonderivater til fröbehandling
DE502004010131D1 (de) Pyridopyrimidinone zur behandlung von krebserkrankungen
IL177455A0 (en) Pyrazoline derivatives useful for the treatment of cancer
EP1789064A4 (en) ENHANCED ANTICANCER TREATMENT
DK1567524T3 (da) Thia-epothilonderivater til behandling af cancer
NO20063114L (no) Enoxaparin for behandling av cancer
NO20055449D0 (no) Fremgangsmate for diagnostisering av behandling av kreft